Skip to main content

The Importance of Early Universal Screening to Identify Congenital CMV (cCMV)

The National CMV Foundation, Leading Physicians cCMV Testing Advocates, and Eurofins Viracor will help you learn more about congenital cytomegalovirus (cCMV) and how early testing with non-invasive sample types (like saliva) can lead to improved outcomes. This succinct and informative webinar will discuss the impact testing can make for neonates at risk, types of testing, and the advocacy work you can get involved with (not only in June, but year round). The great panel also answers viewer's questions after the main presentation.

Length of Presentation: 56 minutes

Presented by: 

  • Dr. Patricia Purcell, MD
    • Assistant Professor, Pediatric Otolaryngology at C.S. Mott Children’s Hospital
  • Dr. Gail Demmler-Harrison, MD
    • Professor, Department of Pediatrics and Pathology and Immunology at Baylor College of Medicine
  • Dr. Steve Kleiboeker, PhD
    • Chief Scientific Officer
    • Eurofins Viracor
  • Amanda Devereaux, RN, BSN
      • Program Director at National CMV Foundation

 

Back to top